Breaking News
FONT-SIZE Plus   Neg
Share SHARE

Dendreon Swings To Profit In Q4 - Quick Facts

RELATED NEWS
Trade DNDN now with 

Dendreon Corp. (DNDN: Quote) reported fourth-quarter profit of $38.1 million or $0.26 per share versus loss of $91.83 million or $0.64 per share a year earlier.

Non-GAAP net income per share-basic was $0.45 versus loss per share-basic of $0.50 last year.

On average, 21 analysts polled by Thomson Reuters expected the company to report loss of $0.23 per share. Analysts' estimates typically exclude special items.

Total revenue surged to $202.15 million from $25 million a year ago. Analysts estimated revenues of $120.80 million.

Product revenue for the quarter was $77 million compared to $25 million in the prior-year quarter.

Click here to receive FREE breaking news email alerts for Dendreon Corp. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Fashion retailer Gap Inc. said Thursday after the markets closed that its second quarter profit rose 10% from last year, helped by higher sales and a gain from asset sale. The company's quarterly earnings per share, excluding items, also came in above analysts' expectations as did its quarter sales. Separately, Gap announced plans to enter India through franchise-operated Gap brand stores in 2015. While buying interest was somewhat subdued, stocks moved mostly higher over the course of the trading day on Thursday. The gains on the day extended the recent upward trend by the markets, lifting the S&P 500 to a new record closing high. Republicans have not found much to like about President Barack Obama's nearly six years in office, but the results of a new Washington Post-ABC News poll show that a vast majority support the president's decision to launch airstrikes in Iraq.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.